• Existing systems of staging for patients with rectal cancer depend almost exclusively on anatomic evidence. Consequently, the stages cannot be determined in advance of therapeutic decisions and cannot be used for patients treated without surgery. Furthermore, the stages contain no provision for important prognostic distinctions that cannot be discerned from anatomic data.
After preparing a taxonomy for hitherto unclassified medical data, we developed and tested two new systems of staging in a cohort of 318 patients. The first system, which can be applied before treatment, is divided into four composite stages that contain elements of symptomatic, chronometric, co-morbid, and para-morbid data, as well as information obtained from physical examination, sigmoidoscopy, and roentgenography. The second system, applicable to patients with resected tumors, is based on a combination of pretherapeutic clinical information and post-surgical anatomic evidence.
The two systems produce prognostic gradients that are clinically distinctive and statistically efficacious.
(Arch Intern Med 135:1441-1453,1975)
Feinstein AR, Schimpff CR, Hull EW. A Reappraisal of Staging and Therapy for Patients With Cancer of the Rectum: I. Development of Two New Systems of Staging. Arch Intern Med. 1975;135(11):1441–1453. doi:10.1001/archinte.1975.00330110031005
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: